CSTL FY 2022 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$137M+45.7% YoY

Gross Profit

$105M76.6% margin

Operating Income

-$73M-53.2% margin

Net Income

-$67M-49.0% margin

EPS (Diluted)

$-2.58

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$47M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$447M

Total Liabilities

$48M

Stockholders' Equity

$399M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$137M	$94M	+45.7%
Gross Profit	$105M	$78M	+34.2%
Operating Income	-$73M	-$40M	-81.8%
Net Income	-$67M	-$31M	-114.6%